Urokinase‐plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

Cancer

Volumn 62, Issue 3, 1988, Pages 531-533

  Duffy, Michael J ^a   O'siorain, Liam ^a   O'grady, Pauline ^a   Devaney, Deirdre ^a   Fennelly, James J ^a   Lijnen, Henri J ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR;

BREAST CARCINOMA; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMAN; NEOPLASM STAGING; PLASMINOGEN ACTIVATORS; PROGNOSIS; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL; URINARY PLASMINOGEN ACTIVATOR;

EID: 0023735157     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19880801)62:3<531::AID-CNCR2820620315>3.0.CO;2-B     Document Type: Article

References (9)

1. The role of proteinases in cellular invasiveness
2. Do proteases play a role in cancer invasion and metastasis?
3. P. Plasminogen activator and cancer
4. Multiple forms of plasminogen activator in human breast tumours
5. Antibodies to plasminogen activator inhibit human tumor metastasis
6. CEA‐like material in cytosols from human breast carcinomas
7. Plasminogen activators in human colorectal neoplasia
8. Plasminogen activator activity and composition in human breast cancer